Loading clinical trials...
Loading clinical trials...
A Multi Center, Randomized, Double-blind, Parallel Design, Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily in Primary Open Angle Glaucoma or Ocular Hypertension Patients.
Conditions
Interventions
D565H(Latanoprost 25㎍/㎖)
D565(Latanoprost 50㎍/㎖)
Locations
1
South Korea
Seoul National University Hosipital
Seoul, Jongno, South Korea
Start Date
March 30, 2017
Primary Completion Date
September 10, 2017
Completion Date
September 30, 2017
Last Updated
July 21, 2017
NCT07390890
NCT05902871
NCT03675412
NCT07218796
NCT07119580
NCT07076303
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions